Additionally, treatment with cisplatin and CHK1 inhibitors led to the upregulation of major histocompatibility complex (MHC) class I associated chains A (MICA) expression through IRF1-mediated transcriptional effects, resulting in increased infiltration of NK cells and CD8+ T cells in HCC tissues [104]. The gene discussed is CHEK1; the disease is hepatocellular carcinoma.